Ibrance (palbociclib) to treat advanced breast cancer

November 28, 2016- Interviewed by Steven E. Greer, MD

We interviewed Richard Finn, MD about his NEJM paper on the Phase-3 study of palbociclib to treat metastatic breast cancer.

This entry was posted in - Biotech, - NEJM, - Pharma, Oncology, UCLA. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *